1. Endings are beginnings.

    Pharos 73(4):1 (2010) PMID 21155113

  2. Meta-analysis of six-month memantine trials in Alzheimer's disease.

    Alzheimer's & Dementia 3(1):7 (2007) PMID 19595910

    Clinical trials have suggested benefits of memantine for all stages of Alzheimer's disease (AD). A meta-analysis of memantine trials in outpatients with probable AD was conducted. Six randomized, placebo-controlled trials fulfilled inclusion criteria. Cognitive, global, functional, behavioral, a...
  3. Geriatric interdisciplinary team training program: evaluation results.

    Journal of Aging and Health 17(4):443 (2005) PMID 16020574

    Geriatric interdisciplinary team training has long been a goal in health education with little progress. In 1997, the John A. Hartford Foundation funded eight programs nationally to create Geriatric Interdisciplinary Team Training (GITT) programs. Faculty trained 1,341 health professions student...
  4. Vitamin E and donepezil for the treatment of mild cognitive impairment.

    New England Journal of Medicine 352(23):2379 (2005) PMID 15829527

    Mild cognitive impairment is a transitional state between the cognitive changes of normal aging and early Alzheimer's disease. In a double-blind study, we evaluated subjects with the amnestic subtype of mild cognitive impairment. Subjects were randomly assigned to receive 2000 IU of vitamin E da...
  5. Meta-analysis of 6-month memantine clinical trials in Alzheimer’s disease

    Alzheimer's & Dementia 1(1):S67 (2005)

  6. Development of a mechatronic assistance system for surgery—on example of microlaryngoscopy

    International Congress Series 1281:642 (2005)

    Laser surgery of the larynx is characterized by a very small working space. The laryngoscope develops a high pressure on maxilla and tongue. During the procedure repeated changes of the position are necessary to provide sufficient view. The mechatronic assistance system should achieve a low...
  7. Operational criteria for patient recruitment in trials of mild cognitive impairment

    Alzheimer's & Dementia 1(1):S87 (2005)

  8. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

    JAMA 289(21):2819 (2003) PMID 12783912

    Laboratory evidence that inflammatory mechanisms contribute to neuronal injury in Alzheimer disease (AD), along with epidemiological evidence, suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) may favorably influence the course of the disease. To determine whether treatment with a sele...
  9. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.

    Schizophrenia Bulletin 29(1):57 (2003) PMID 12908661

    This article describes the development of the protocol for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Alzheimer's disease trial, which was developed in collaboration with the National Institute of Mental Health to assess the effectiveness of atypical antipsychotics f...
  10. Clinical Diversity in Late Onset Alzheimer's Disease

    American Journal of Geriatric Psychiatry 2(2):177 (1994)

  11. A dynamic equilibrium in GSR habituation: The effect of interstimulus interval

    Journal of Psychosomatic Research 6(2):117 (1962)

    Habituation occurs in a dynamic equilibrium dependent on the inter-stimulus interval. After the first few tone stimuli the degree of habituation is related to the inter-trial interval, the shorter the interval, the greater the level of the habituation; the longer the interval the less the h...